103421-59-6

Basic information

• Product Name: Benzamide, 2-chloro-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin -3-yl)-, (S)-
• CAS NO: 103421-59-6
• Molecular Formula: C23H18ClN3O2
• Molecular Weight: 403.868
• Mol File: 103421-59-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzamide, 2-chloro-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin -3-yl)-, (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, 2-chloro-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin -3-yl)-, (S)-(103421-59-6)
• EPA Substance Registry System: Benzamide, 2-chloro-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin -3-yl)-, (S)-(103421-59-6)

Safety Data

• Hazardous Substances Data: 103421-59-6(Hazardous Substances Data)

Upstream product

• 609-65-4 o-chlorobenzoyl chloride 
• 103343-66-4 (S)-3-amino-1-methyl-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one 

Relevant articles and documents

Methods for Drug Discovery: Development of Potent, Selective, Orally Effecive Cholecystokinin Antagonists

3-(Acylamino)-5-phenyl-2H-1,4-benzodiazepines, antagonists of the peptide hormone cholecystokinin (CCK), are described.Developed by reasoned modification of the known anxiolytic benzodiazepines, these compounds provide highly potent, orally effective ligands selective for peripheral (CCK-A) receptors, with binding affinities approaching or equaling that of the natural ligand CCK-8.The distinction between CCK-A receptors on the one hand and CNS (CCK-B), gastrin, and central benzodiazepine receptors on the other is demonstrated by using the structure-activity profiles of the new compounds.Details of the binding of these agents to CCK-A receptors are examined, and the method of development of these compounds is discussed in terms of its relevance to the general problem of drug discovery.